Investment firm Baird has announced the downgrade of Apellis Pharmaceuticals Inc. stock rating from "outperform" to "neutral"
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Meanwhile, the institution has significantly lowered its target stock price from $52 to $41.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Michael Saylor: Strategy Does Not Rule Out Selling Some Bitcoin by 2026
BlockBeats•2026/05/23 03:26
Federal Reserve Whisper Network Recaps Powell's Four Key Moments
BlockBeats•2026/05/23 00:33
Commerzbank: The progress of the Iran war remains crucial for the euro’s outlook
老虎证券•2026/05/22 14:25
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$76,653.63
+1.69%
Ethereum
ETH
$2,116
+2.68%
Tether USDt
USDT
$0.9988
-0.01%
BNB
BNB
$654.51
+0.95%
XRP
XRP
$1.36
+1.90%
USDC
USDC
$0.9997
-0.00%
Solana
SOL
$85.87
+1.84%
TRON
TRX
$0.3625
+0.25%
Dogecoin
DOGE
$0.1027
+1.90%
Hyperliquid
HYPE
$61.03
+10.69%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now